ReaLigands: A Ligand Library Cultivated from Experiment and Intended for Molecular Computational Catalyst Design
Shu-Sen Chen1, Zack Meyer1, Brendan Jensen1
1Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah 84604 United States.
Journal of Chemical Information and Modeling
|November 21, 2023
Summary
This study introduces the ReaLigands library, a collection of over 30,000 ligands derived from crystal structures. This resource accelerates computational catalyst design by providing readily available, synthesizable ligand options.
Area of Science:
- Computational Chemistry
- Materials Science
- Catalysis
Background:
- Computational catalyst design necessitates identifying optimal metal-ligand combinations for desired reactivity and selectivity.
- A significant barrier exists in evaluating the synthesizability of computationally proposed ligands for experimental validation.
Purpose of the Study:
- To address the challenge of ligand synthesizability in computational catalyst design.
- To introduce the ReaLigands library, a comprehensive database of experimentally validated ligands.
Main Methods:
- Developed the ReaLigands library by extracting >30,000 ligands from crystal structures using a modified depth-first search algorithm.
- Assigned charges to ligands using a machine learning model trained on quantum-chemical features.
- Employed principal component analysis (PCA) and uniform manifold approximation and projection (UMAP) for ligand analysis and categorization.
Main Results:
- The ReaLigands library contains diverse monodentate, bidentate, tridentate, and larger ligands, sorted by connectivity and denticity.
- PCA and UMAP analyses revealed the structural diversity and interconnections within tridentate ligand categories.
- Demonstrated library utility by rapidly generating reaction barriers for 750 bidentate ligands in a Rh-hydride ethylene migratory insertion reaction.
Conclusions:
- The ReaLigands library significantly facilitates the translation of computational catalyst designs into experimental practice.
- This resource accelerates the discovery and optimization of novel catalysts by providing a curated set of synthesizable ligands.
More Related Videos
Related Concept Videos
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Metal-Ligand Bonds
20.8K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
20.8K
Drug-Receptor Bonds
2.9K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.9K
The Two-State Receptor Model
2.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.0K


